National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism.
Obstetric venous thromboembolism is a leading cause of severe maternal morbidity and mortality. Maternal death from thromboembolism is amenable to prevention, and thromboprophylaxis is the most readily implementable means of systematically reducing the maternal death rate. Observational data support the benefit of risk-factor-based prophylaxis in reducing obstetric thromboembolism. This bundle, developed by a multidisciplinary working group and published by the National Partnership for Maternal Safety under the guidance of the Council on Patient Safety in Women's Health Care, supports routine thromboembolism risk assessment for obstetric patients, with appropriate use of pharmacologic and mechanical thromboprophylaxis. Safety bundles outline critical clinical practices that should be implemented in every maternity unit. The safety bundle is organized into four domains: Readiness, Recognition, Response, and Reporting and Systems Learning. Although the bundle components may be adapted to meet the resources available in individual facilities, standardization within an institution is strongly encouraged.
Columbia University College of Physicians and Surgeons, New York, New York; the Society for Obstetric Anesthesia and Perinatology, Milwaukee, Wisconsin; Kaiser Permanente Riverside Medical Center, Riverside, California; Yale Women and Children's Center for Blood Disorders and Preeclampsia Advancement, New Haven, Connecticut; the Association of Women's Health, Obstetric and Neonatal Nurses, Washington, DC; the American Academy of Family Physicians, Leawood, Kansas; California Maternal Quality Care Collaborative, Stanford, California; the American College of Nurse-Midwives, Silver Spring, Maryland; the American College of Obstetricians and Gynecologists, Washington, DC; and Baylor College of Medicine/Texas Children's Hospital, Houston, Texas.
Mary E
ME
DʼAlton
Alexander M
AM
Friedman
Richard M
RM
Smiley
Douglas M
DM
Montgomery
Michael J
MJ
Paidas
Robyn
R
DʼOria
Jennifer L
JL
Frost
Afshan B
AB
Hameed
Deborah
D
Karsnitz
Barbara S
BS
Levy
Steven L
SL
Clark
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D002585:Cesarean Section; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D036801:Parturition; D058725:Peripartum Period; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000453:epidemiology / Q000517:prevention & control*; D018570:Risk Assessment; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis; D013997:Time Factors; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight